JAFHX Performance — U.S. Growth Trust, Series I
Data updated: 2026-08-27
JAFHX returned +6.16% year to date and +18.02% over one year to Jun 2026. Annualised returns are +23.20% over 3 years and +10.88% over 5 years. The fund beat its US Large Growth category average: $100 invested three years ago grew to $187, against $175 for the category, and to $118 over one year, against $117. Volatility over the past three years was 17.40% a year. In the 12 months to Jun 2026 the fund lost a net $4.7M, and assets reached $747.40M.
JAFHX Growth of $100
What $100 invested in U.S. Growth Trust grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Growth category average over the same months.
| Period | JAFHX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $118 | $117 |
| 3 years (Jul 2023 – Jun 2026) | $187 | $175 |
| 5 years (Jul 2021 – Jun 2026) | $168 | $166 |
| Since data start (Jul 2019 – Jun 2026) | $317 | $271 |
JAFHX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +6.16% |
| 1 year | +18.02% |
| 3 years (annualised) | +23.20% |
| 5 years (annualised) | +10.88% |
JAFHX Annual Returns
Calendar-year total returns of U.S. Growth Trust, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +6.16% |
| 2025 | +20.61% |
| 2024 | +30.82% |
| 2023 | +52.84% |
| 2022 | −37.71% |
| 2021 | +15.76% |
| 2020 | +56.04% |
| 2019 (Jul–Dec) | +9.98% |
JAFHX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −0.4% | −4.4% | −5.4% | +12.3% | +6.1% | −1.1% | — | — | — | — | — | — |
| 2025 | +3.3% | −3.3% | −10.0% | +3.3% | +9.1% | +7.1% | +3.2% | +1.0% | +3.9% | +3.1% | −0.1% | −0.3% |
| 2024 | +4.5% | +8.3% | +0.7% | −5.1% | +5.1% | +6.6% | −3.2% | +3.1% | +1.5% | −0.1% | +6.6% | +0.2% |
| 2023 | +10.7% | −1.4% | +8.4% | +1.3% | +6.9% | +6.9% | +3.1% | −1.3% | −5.5% | −1.3% | +12.4% | +4.7% |
| 2022 | −11.9% | −5.6% | +3.5% | −14.1% | −5.8% | −7.9% | +13.3% | −4.6% | −9.2% | +5.0% | +3.2% | −8.6% |
| 2021 | −1.1% | +0.9% | −3.0% | +7.6% | −2.4% | +8.3% | +2.6% | +3.5% | −5.6% | +8.6% | −0.8% | −2.7% |
| 2020 | +4.5% | −5.7% | −10.5% | +15.4% | +9.5% | +7.2% | +8.2% | +13.4% | −5.5% | −4.5% | +12.6% | +4.8% |
| 2019 | — | — | — | — | — | — | +0.5% | −1.6% | −1.2% | +3.1% | +6.3% | +2.7% |
JAFHX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 17.40%
- 3-year Sharpe ratio: 1.07 (vs 4.5% risk-free rate)
- Best month: +12.38% (Nov 2023)
- Worst month: −9.97% (Mar 2025)
JAFHX Fund Flows
Monthly money in and out of U.S. Growth Trust, from SEC Form N-PORT.
- 12-month net flow: −$4.7M
- 12-month gross sales (incl. reinvestments): $89.5M
- Sales ÷ redemptions: 0.95×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $405K | $7.4M | −$7.0M |
| May 2026 | $967K | $6.6M | −$5.6M |
| Apr 2026 | $1.7M | $6.8M | −$5.1M |
| Mar 2026 | $1.4M | $8.2M | −$6.8M |
| Feb 2026 | $945K | $8.1M | −$7.1M |
| Jan 2026 | $180K | $8.9M | −$8.8M |
| Dec 2025 | $587K | $9.4M | −$8.8M |
| Nov 2025 | $612K | $8.0M | −$7.4M |
| Oct 2025 | $76.8M | $9.6M | $67.2M |
| Sep 2025 | $2.5M | $7.5M | −$5.1M |
| Aug 2025 | $1.0M | $6.7M | −$5.7M |
| Jul 2025 | $2.4M | $7.1M | −$4.7M |
JAFHX Assets Under Management
Net assets of U.S. Growth Trust by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $747.40M |
| 2026-03-31 | $649.86M |
| 2025-12-31 | $744.67M |
| 2025-09-30 | $748.57M |
| 2025-06-30 | $706.67M |
| 2025-03-31 | $606.76M |
| 2024-12-31 | $686.31M |
| 2024-09-30 | $659.80M |
| 2024-06-30 | $673.96M |
| 2024-03-31 | $647.76M |
| 2023-12-31 | $581.96M |
| 2023-09-30 | $512.55M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.